Ingalls & Snyder LLC Ligand Pharmaceuticals Inc Transaction History

Ingalls & Snyder LLC

  • $2.55 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 21, 2021
SELL
$99.52 - $215.83 $277,660 - $602,165
-2,790 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$80.55 - $106.05 $41,886 - $55,146
520 Added 22.91%
2,790 $277,000
Q3 2020

Oct 21, 2020
BUY
$89.56 - $126.72 $203,301 - $287,654
2,270 New
2,270 $216,000

Others Institutions Holding LGND

# of Institutions
275
Shares Held
18.5M
Call Options Held
28.8K
Put Options Held
7K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.03B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email